Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Healthequity (HQY)
NASDAQ:HQY
Holding HQY?
Track your performance easily
See the Price Targets and Ratings of:
HQY Analyst Ratings
Strong Buy
10 Buy
1 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
HQY Stock 12 Month Forecast
Average Price Target
$108.27
▲(3.90% Upside)
| Highest Price Target$130.00 | Average Price Target$108.27 | Lowest Price Target$100.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Wells Fargo
Reiterated
11/17/24
Goldman Sachs
Initiated
11/14/24
Bank of America Securities
Reiterated
11/13/24
Barclays
Assigned
11/13/24
BTIG
Reiterated
11/13/24
J.P. Morgan
Reiterated
09/30/24
Barrington
Reiterated
09/20/24
RBC Capital
Assigned
09/19/24
KeyBanc
Reiterated
09/18/24
Deutsche Bank
Reiterated
09/04/24
JMP Securities
$105
Buy
0.76%
Upside
Reiterated
09/04/24
JMP Securities Reaffirms Their Buy Rating on Healthequity (HQY)
Raymond James
$100→$105
Buy
0.76%
Upside
Reiterated
06/07/24
HealthEquity price target raised to $105 from $100 at Raymond JamesHealthEquity price target raised to $105 from $100 at Raymond James
Jefferies
$95
Buy
-8.84%
Downside
Reiterated
06/04/24
Jefferies Remains a Buy on Healthequity (HQY)
Robert W. Baird
$98→$104
Buy
-0.20%
Downside
Assigned
06/03/24
HealthEquity price target raised to $104 from $98 at BairdHealthEquity price target raised to $104 from $98 at Baird
Guggenheim
$110
Buy
5.56%
Upside
Reiterated
12/06/23
We reiterate our BUY rating and $110PT on HQY after the company's solid beat & raise in 3Q. However, most impressive to us is the expected ~3% cash AUM yield in ~47bps decline in the 5Y TSY since we updated our model on 10/13 (we had modeled 2.93% when the 5Y was at 4.64%). In our view, this illustrates the yield lift associated with HQY's enhanced rates products, which even our near Street high model did not fully appreciate. Going forward, we expect HQY to convert ~75% of the higher yields to gross profit (with some give-back at the Service revenue line), which should propel EBITDA growth of ~25% in F25E. Trading at 16x NTM Street EBITDA (which needs to come up to guidance), we don't think the EBITDA growth story is getting its due credit, and think ~25x makes more sense. With ~60% upside potential, HQY remains our Best Idea.
Best Analysts Covering Healthequity
Which Analyst Should I Follow If I Want to Buy HQY and Sell After:
1 Month
xxx
Success Rate
15/23 ratings generated profit
Average Return
+0.79%
reiterated a xxx
rating 6 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 65.22% of your transactions generating a profit, with an average return of +0.79% per trade.
3 Months
xxx
Success Rate
13/20 ratings generated profit
Average Return
+4.69%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 65.00% of your transactions generating a profit, with an average return of +4.69% per trade.
1 Year
Success Rate
21/23 ratings generated profit
Average Return
+22.32%
reiterated a buy rating 6 days ago
Copying Stan Berenshteyn's trades and holding each position for 1 Year would result in 91.30% of your transactions generating a profit, with an average return of +22.32% per trade.
2 Years
xxx
Success Rate
23/23 ratings generated profit
Average Return
+38.30%
reiterated a xxx
rating 6 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +38.30% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
HQY Analyst Recommendation Trends
Rating
Jul 24
Aug 24
Sep 24
Oct 24
Nov 24
Strong Buy
0
1
1
1
0
Buy
20
16
20
19
22
Hold
0
0
0
0
1
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
20
17
21
20
23
Each month's total comprises the sum of three months' worth of ratings.
HQY Financial Forecast
HQY Stock Forecast FAQ
What is HQY’s average 12-month price target, according to analysts?
Based on analyst ratings, Healthequity’s 12-month average price target is $108.27.
What is HQY’s upside potential, based on the analysts’ average price target?
Healthequity has 3.90% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is HQY a Buy, Sell or Hold?
Healthequity has a consensus rating of Strong Buy which is based on 10 buy ratings, 1 hold ratings and 0 sell ratings.
What is Healthequity’s price target?
The average price target for Healthequity is $108.27. This is based on 11 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $130.00 ,the lowest forecast is $100.00. The average price target represents 3.90% Increase from the current price of $104.21.
The highest analyst price target is $130.00 ,the lowest forecast is $100.00. The average price target represents 3.90% Increase from the current price of $104.21.
What do analysts say about Healthequity?
Healthequity’s analyst rating consensus is a Strong Buy. This is based on the ratings of 11 Wall Streets Analysts.
How can I buy shares of HQY?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.